CIK 0001512762
- Accelerated filer
- Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273615821
- Phone
- +1 650-649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Scientific Officer sold 17,535 shares at $15.02 ($263,300)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 600 shares at $15.00 ($9,000)
- 4 Open-market sale Chief Scientific Officer sold 11,333 shares at an average $20.32 ($230,292)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition Director disposed of 400,000 shares (other)
- 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $20.00 ($226,626)
- 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $20.73 ($234,985)
- 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $24.19 ($274,171)
- 4 Open-market sale Chief Scientific Officer sold 11,333 shares at $27.37 ($310,155)
- 4 Open-market sale Chief Financial Officer sold 3,900 shares at $27.00 ($105,300)
Page 14 of 20 · 399 filings